August 22, 2025 • 2 mins
NRx Pharmaceuticals, listed on NASDAQ as NRXP, has filed a Citizen Petition asking the FDA to prohibit the use of benzethonium chloride in ketamine products due to its toxic nature. The company has presented evidence supporting the safety and stability of their preservative-free ketamine, 'NRX-100', and is also seeking FDA approval for their oral NMDA-targeting drug, 'NRX-101'. Learn more about NRx Pharmaceuticals and stay updated on industry news at PsychedelicNewsWire.com.
Mark as Played
Popular Podcasts
Las Culturistas with Matt Rogers and Bowen Yang
Ding dong! Join your culture consultants, Matt Rogers and Bowen Yang, on an unforgettable journey into the beating heart of CULTURE. Alongside sizzling special guests, they GET INTO the hottest pop-culture moments of the day and the formative cultural experiences that turned them into Culturistas. Produced by the Big Money Players Network and iHeartRadio.
The Joe Rogan Experience
The official podcast of comedian Joe Rogan.
Stuff You Should Know
If you've ever wanted to know about champagne, satanism, the Stonewall Uprising, chaos theory, LSD, El Nino, true crime and Rosa Parks, then look no further. Josh and Chuck have you covered.